Human apolipoproteins A-I and A-II in cell cholesterol efflux: Studies with transgenic mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 9, 1998, Pages 1417-1423

  Chiesa, Giulia ^a   Parolini, Cinzia ^a   Canavesi, Monica ^a   Colombo, Nicoletta ^a   Sirtori, Cesare R ^a   Fumagalli, Remo ^a   Franceschini, Guido ^a   Bernini, Franco ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Atherosclerosis; HDL; Phospholipids; Reverse cholesterol transport; Tissue culture cells

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; EXTRACELLULAR SPACE; GENE TARGETING; HYPERLIPIDEMIA; IMMUNOAFFINITY CHROMATOGRAPHY; INTERSTITIAL FLUID; LIPID COMPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS; TISSUE CULTURE; TRANSGENIC MOUSE;

EID: 0031664803     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.9.1417     Document Type: Article

References (26)

1. Gordon DJ, Rifkind BM. High-density lipoprotein: the clinical implication of recent studies. N Engl J Med. 1989;321:1311-1316.
2. Glomset JA. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968;9:155-162.
3. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res. 1995;36:211-228.
4. Ho YK, Brown MS, Goldstein JL. Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoprotein and other agents. J Lipid Res. 1980;21:391-398.
5. Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein. Biochemistry. 1988;27:25-29.
6. Barkia A, Puchois P, Ghalim N, Torpier G, Barbaras R, Ailhaud G, Fruchart JC. Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells. Atherosclerosis. 1991;87:135-146.
7. Oikawa S, Mendez AJ, Oram JF, Bierman EL, Cheung MC. Effects of high-density lipoprotein particles containing apo A-I, with or without apo A-II, on intracellular cholesterol efflux. Biochim Biophys Acta. 1993;1165:327-334.
8. Mahlberg FH, Glick JM, Lund-Katz S, Rothblat GH. Influence of apolipoproteins AI, AII, and Cs on the metabolism of membrane and lysosomal cholesterol in macrophages. J Biol Chem. 1991;266:19930-19937.
9. Mahlberg FH, Rothblat GH. Cellular cholesterol efflux: role of cell membrane kinetic pools and interaction with apolipoproteins AI, AII, and Cs. J Biol Chem. 1992;267:4541-4550.
10. Davidson WS, Lund-Katz S, Johnson WJ, Anantharamaiah GM, Palgunachari MN, Segrest JP, Rothblat GH, Phillips MC. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein. J Biol Chem. 1994;269:22975-22982.
11. Gillotte CL, Davidson WS, Lund-Katz S, Rothblat GH, Phillips MC. Apolipoprotein A-I structural modification and the functionality of reconstituted high density lipoprotein particles in cellular cholesterol efflux. J Biol Chem. 1996;271:23792-23798.
12. Davidson WS, Gillotte CL, Lund-Katz S, Johnson WJ, Rothblat GH, Phillips MC. The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol. J Biol Chem. 1995;270:5882-5890.
13. Davidson WS, Rodrigueza WV, Lund-Katz S, Johnson WJ, Rothblat GH, Phillips MC. Effects of acceptors particle size on the efflux of cellular free cholesterol. J Biol Chem. 1995;270:17106-17113.
14. Agnani G, Marcel YL. Cholesterol efflux from fibroblasts to discoidal lipoproteins with apolipoprotein A-I (LpA-I) increases with particles size but cholesterol transfer from LpA-I to lipoproteins decreases with size. Biochemistry. 1993;32:2643-2649.
15. de la Llera Moya M, Atger V, Paul JL, Fournier N, Moatti N, Giral P, Freeday KE, Rothblat G. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Arterioscler Thromb Vasc Biol. 1994;14:1056-1065.
16. Atger V, de la Llera Moya M, Bamberger M, Francone O, Cosgrove P, Tall A, Walsh A, Moatti N, Rothblat G. Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI. J Clin Invest. 1995;96:2613-2622.
17. Fournier N, de la Llera Moya M, Burkey BF, Swaney JB, Paterniti J Jr, Moatti N, Atger V, Rothblat GH. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apo A-I transgenic rats. J Lipid Res. 1996;37:1704-1711.
18. Williamson R, Lee D, Hagaman J, Maeda N. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc Natl Acad Sci U S A. 1992;89:7134-7138.
19. Schultz JR, Gong EL, McCall MR, Nichols AV, Clift SM, Rubin EM. Expression of human apolipoprotein A-H and its effect on high density lipoproteins in transgenic mice. J Biol Chem. 1992;267:21630-21636.
20. Schultz JR, Verstuyft JG, Gong EL, Nichols AV, Rubin EM. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature. 1993;365:762-764.
21. Allain CC, Poon LS, Chan CS, Richmond W. Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
22. Takayama M, Itoh S, Nagasaki T, Tanimizu I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta. 1977;79:93-96.
23. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
24. Schägger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem. 1987;166:368-379.
25. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 1986;128:417-431.
26. Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res. 1984;25:1277-1294.